Evidence map›Paper›PMID 34718629›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities.

Archana Radhakrishnan, David Reyes-Gastelum, Paul Abrahamse, Brittany Gay, Sarah T Hawley, Lauren P Wallner, Debbie W Chen, Ann S Hamilton, Kevin C Ward, Megan R Haymart

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Team-Based Care for Thyroid Cancer: What Is the Role of the Primary Care Physician?Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2024
    Article
  3. Physical Examination of the Thyroid: Accuracy in Detecting Thyroid Nodules and Frequency of Additional Findings.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2024
    Observational
  4. Review
  5. Review
  6. Identifying and Addressing Health Disparities in Thyroid Cancer Care.The Journal of clinical endocrinology and metabolism · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Archana RadhakrishnanDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
David Reyes-GastelumDivision of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.
Paul AbrahamseDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Brittany GayDivision of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.
Sarah T HawleyDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Lauren P WallnerDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Debbie W ChenDivision of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.
Ann S HamiltonDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Kevin C WardDepartment of Epidemiology, Emory University, Atlanta, GA 30322, USA.
Megan R HaymartDivision of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0002-1083-1575

Funding

CALIFORNIA COORDINATED CANCER PREVENTION & CONTROL PROGRAMU58DP003862 · DP · CALIFORNIA STATE DEPT OF PUBLIC HEALTH · PI SNIPES, KURT P · 2012 to 2014
$31.5M
Treatment decision making in low-risk thyroid cancerR01CA201198 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAYMART, MEGAN RIST · 2016 to 2019
$2.4M
Engaging PCPs to optimize active surveillance of low-risk prostate cancerK08CA245237 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RADHAKRISHNAN, ARCHANA · 2019 to 2023
$1.2M
Imaging Practices and Overdiagnosis of Thyroid CancerR01HS024512 · AHRQ · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAYMART, MEGAN RIST · 2016 to 2019
$861k
AHRQ HHS R01 HS024512NCCDPHP CDC HHS U58 DP003862NCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS K08 CA245237NCI NIH HHS R01 CA201198NIH HHS K08 CA245237.
6 · The paper itself

Abstract

contextLittle is known about provider specialties involved in thyroid cancer diagnosis and management.

objectiveCharacterize providers involved in diagnosing and treating thyroid cancer. DESIGN/SETTING/

participantsWe surveyed patients with differentiated thyroid cancer from the Georgia and Los Angeles County Surveillance, Epidemiology and End Results registries (N = 2632, 63% response rate). Patients identified their primary care physicians (PCPs), who were also surveyed (N = 162, 56% response rate).

main outcome measures(1) Patient-reported provider involvement (endocrinologist, surgeon, PCP) at diagnosis and treatment; (2) PCP-reported involvement (more vs less) and comfort (more vs less) with discussing diagnosis and treatment.

resultsAmong thyroid cancer patients, 40.6% reported being informed of their diagnosis by their surgeon, 37.9% by their endocrinologist, and 13.5% by their PCP. Patients reported discussing their treatment with their surgeon (71.7%), endocrinologist (69.6%), and PCP (33.3%). Physician specialty involvement in diagnosis and treatment varied by patient race/ethnicity and age. For example, Hispanic patients (vs non-Hispanic White) were more likely to report their PCP informed them of their diagnosis (odds ratio [OR]: 1.68; 95% CI, 1.24-2.27). Patients ≥65 years (vs <45 years) were more likely to discuss treatment with their PCP (OR: 1.59; 95% CI, 1.22-2.08). Although 74% of PCPs reported discussing their patients' diagnosis and 62% their treatment, only 66% and 48%, respectively, were comfortable doing so.

conclusionsPCPs were involved in thyroid cancer diagnosis and treatment, and their involvement was greater among older patients and patients of minority race/ethnicity. This suggests an opportunity to leverage PCP involvement in thyroid cancer management to improve health and quality of care outcomes for vulnerable patients.

Indexed as

Healthcare DisparitiesQuality ImprovementAdultCohort StudiesEndocrinologistsFemaleHumansMaleMiddle AgedPhysicians, Primary CarePractice Patterns, Physicians'Referral and ConsultationSEER ProgramSurgeonsSurveys and QuestionnairesThyroid Neoplasmsendocrinologistshealthcare disparitiesphysiciansprimary caresurgeonsthyroid neoplasms

Identifiers

PMID34718629
PMCPMC8852205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.